Risk of Switch to Mania/Hypomania in Bipolar Depressive Patients Treated with Antidepressants: A Real-World Study.

Health data science Pub Date : 2025-06-03 eCollection Date: 2025-01-01 DOI:10.34133/hds.0209
Lei Feng, Weiwei Wang, Can Yin, Jing Li, Xinwei Zhang, Xiaotian Chang, Zizhao Feng, Mui Van Zandt, Seng Chan You, Sarah Seager, Christian Reich, Siyan Zhan, Feng Sun, Gang Wang
{"title":"Risk of Switch to Mania/Hypomania in Bipolar Depressive Patients Treated with Antidepressants: A Real-World Study.","authors":"Lei Feng, Weiwei Wang, Can Yin, Jing Li, Xinwei Zhang, Xiaotian Chang, Zizhao Feng, Mui Van Zandt, Seng Chan You, Sarah Seager, Christian Reich, Siyan Zhan, Feng Sun, Gang Wang","doi":"10.34133/hds.0209","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The use of antidepressants in the treatment of bipolar depression remains controversial due to concerns about their potential to induce mood polarity switches. This multinational observational study aims to examine the association between the use of antidepressants and the risk of hypomanic/manic switch among bipolar depressive patients. <b>Methods:</b> Four electronic health record databases (IQVIA Disease Analyzer Germany, IQVIA Disease Analyzer France, IQVIA US Hospital Charge Data Master, and Beijing Anding Hospital) and one administrative claims database (IQVIA US Open Claims) were analyzed, and the study period covered from January 2013 until December 2017. Treatment patterns of patients with bipolar depression were collected. The hazard ratio (HR) was calculated by comparing the incidence of hypomanic/manic switch in patients who received antidepressants (AD group) with that in those who did not receive any antidepressant (non-AD group) in 730 days after the date of the first diagnosis of bipolar depression. <b>Results:</b> The analysis included a total of 122,843 patients from the 5 databases; 60.6% of them received antidepressants for bipolar depression. Across the 5 data sources, the mean age at index date ranged from 37.50 (15.72) to 52.10 (16.22) years. After controlling potential confounders by propensity score matching, the AD group's manic switch risk was not significantly higher than the non-AD group's (HR 1.04 [95% CI, 0.96 to 1.13]; <i>P</i> = 0.989). Additionally, no statistically significant difference was observed between patients prescribed antimanic drugs and those who were not (HR 0.69 [95% CI, 0.38 to 1.25]; <i>P</i> = 0.535). <b>Conclusions:</b> This study indicated that antidepressants were widely used in clinical settings for managing bipolar depression. The use of antidepressants was not associated with the risk of mania/hypomania switch when compared to non-antidepressants treatment. Therefore, antidepressants could be considered a treatment option for bipolar depression.</p>","PeriodicalId":73207,"journal":{"name":"Health data science","volume":"5 ","pages":"0209"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12130621/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health data science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34133/hds.0209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The use of antidepressants in the treatment of bipolar depression remains controversial due to concerns about their potential to induce mood polarity switches. This multinational observational study aims to examine the association between the use of antidepressants and the risk of hypomanic/manic switch among bipolar depressive patients. Methods: Four electronic health record databases (IQVIA Disease Analyzer Germany, IQVIA Disease Analyzer France, IQVIA US Hospital Charge Data Master, and Beijing Anding Hospital) and one administrative claims database (IQVIA US Open Claims) were analyzed, and the study period covered from January 2013 until December 2017. Treatment patterns of patients with bipolar depression were collected. The hazard ratio (HR) was calculated by comparing the incidence of hypomanic/manic switch in patients who received antidepressants (AD group) with that in those who did not receive any antidepressant (non-AD group) in 730 days after the date of the first diagnosis of bipolar depression. Results: The analysis included a total of 122,843 patients from the 5 databases; 60.6% of them received antidepressants for bipolar depression. Across the 5 data sources, the mean age at index date ranged from 37.50 (15.72) to 52.10 (16.22) years. After controlling potential confounders by propensity score matching, the AD group's manic switch risk was not significantly higher than the non-AD group's (HR 1.04 [95% CI, 0.96 to 1.13]; P = 0.989). Additionally, no statistically significant difference was observed between patients prescribed antimanic drugs and those who were not (HR 0.69 [95% CI, 0.38 to 1.25]; P = 0.535). Conclusions: This study indicated that antidepressants were widely used in clinical settings for managing bipolar depression. The use of antidepressants was not associated with the risk of mania/hypomania switch when compared to non-antidepressants treatment. Therefore, antidepressants could be considered a treatment option for bipolar depression.

抗抑郁药治疗双相抑郁患者转向躁狂/轻躁狂的风险:一项真实世界的研究
背景:在双相抑郁症的治疗中使用抗抑郁药仍然存在争议,因为担心它们可能诱发情绪极性转换。这项跨国观察性研究旨在研究抗抑郁药的使用与双相抑郁患者轻躁/躁狂转换风险之间的关系。方法:对4个电子健康档案数据库(德国IQVIA疾病分析数据库、法国IQVIA疾病分析数据库、美国IQVIA医院收费数据库和北京安定医院数据库)和1个行政索赔数据库(美国IQVIA公开索赔数据库)进行分析,研究时间为2013年1月至2017年12月。收集双相抑郁症患者的治疗模式。风险比(HR)是通过比较首次诊断双相抑郁症后730天内接受抗抑郁药物治疗的患者(AD组)与未接受抗抑郁药物治疗的患者(非AD组)的轻躁/躁狂转换发生率来计算的。结果:共纳入5个数据库的122,843例患者;60.6%的人接受了双相抑郁症的抗抑郁药物治疗。在5个数据源中,指数日的平均年龄为37.50(15.72)~ 52.10(16.22)岁。通过倾向评分匹配控制潜在混杂因素后,AD组躁狂转换风险不显著高于非AD组(HR 1.04 [95% CI, 0.96 ~ 1.13];P = 0.989)。此外,服用抗躁狂药物的患者与未服用抗躁狂药物的患者之间无统计学差异(HR 0.69 [95% CI, 0.38 ~ 1.25];P = 0.535)。结论:本研究表明抗抑郁药被广泛应用于临床治疗双相抑郁症。与非抗抑郁药物治疗相比,抗抑郁药物的使用与躁狂/轻躁狂转换的风险无关。因此,抗抑郁药可以被认为是双相抑郁症的一种治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信